Current findings led to the identification of ferritin as a potential noninvasive predictive biomarker of NAFLD, whose surrogate value increased when combined with other routine biochemical measurements (glucose/ALT). Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.